OBJECTIVES: Although many studies have evaluated the impact of obesity on various medical treatments, it is not known whether obesity is related to late mortality with implantation of small aortic prostheses. This study evaluated the effect of obesity on the late survival of patients after aortic valve replacement (AVR) with implantation of a small aortic prosthesis (size ≤21 mm).
INTRODUCTION
The aortic annulus of Chinese individuals is typically smaller than that of people of European descent and, thus, our hospital in China treats many patients who have a small aortic annulus in aortic valve replacement (AVR). Techniques developed to expand the annulus [1] were rarely applied in clinical circumstances, because these techniques may increase the complexity and risk in an operation [2] ; most surgeons prefer to use a small aortic prosthesis instead of expanding the annulus. Yet, the use of a small aortic prosthesis may be associated with obstruction of the left ventricular output, resulting in a higher transvalvular gradient and patient-prosthesis mismatch (PPM). Rao et al. [3] have demonstrated that mortality was higher in patients receiving a small aortic prosthesis.
Further complicating the issue, there has been a rapid increase in the obese population in recent decades, and obesity has become an important factor that seriously affects the health of Chinese people [4] . However, it is unclear whether obesity is related to later mortality in AVR. Here, we report on 307 patients from a single centre in China who underwent AVR with small prostheses (size ≤21 mm); our long-term follow-up study investigated whether obesity was an independent predictor of longterm mortality for these patients after AVR.
Patients and methods
From January 1998 through December 2008, a total of 328 patients underwent primary AVR (size ≤21 mm) at the Department of Cardiovascular Surgery of Qilu Hospital, Shandong University, Jinan, China. Twenty-one (6.4%) of the 328 patients died within 30 days following surgery and were excluded from the study. The study population was composed of 307 patients (mean age 56 ± 12.6), 58.3% (n = 179) of whom were female. Rheumatic disease accounted for 44.3% (n = 136) of the aetiology, congenital bicuspid valve 25.5% (n = 78), degenerative calcific disease 22.4% (n = 69) and endocarditis 7.8% (n = 24). Hundred and twenty-five (40.7%) patients received a bioprosthesis. Preoperative coronary angiography was performed in all patients aged ≥50 years and in all patients with angina or in those with suspected coronary artery disease. Fifty-four (17.5%) patients underwent concomitant coronary artery bypass graft surgery (CABG). Table 1 presents the distribution of the prosthesis models implanted in this series.
Data collection
Preoperative and operative data were retrospectively collected and validated (Table 1) . Most patients were contacted regularly at our institution; some patients or their first-degree relatives were interviewed via telephone, e-mail, mail or out-patient pathways to confirm mortality and to obtain information, including weight, height, symptoms, capacity for action and results of twodimensional and Dopper echocardiography. Mortalities among the remaining patients (1.8%, n = 8) were determined using the national death and survival data registry.
Body mass index definition
We adopted the most commonly used body mass index (BMI) classification system for adults in China [5] . Patients were classified as normal weight if BMI was <24 kg/m 2 , overweight if BMI 24-27.9 kg/m 2 and obese if BMI ≥28 kg/m 2 . The cohort was divided into three groups according to the BMI: normal weight (n = 185, 60.2%), overweight (n = 94, 30.6%) and obese (n = 28, 9.2%).
Statistical methods
Preoperative and operative data are expressed as mean ± standard deviation or percentages. Repeated-measures analysis of variance (ANOVA) was used to test the significance of changes in data in the different groups of the study; and the Sheffe post hoc test was utilized for multiple comparisons. The χ 2 analysis or Fisher's exact test was used to compare categorical data. Cumulative probability of survival was analysed by constructing Kaplan-Meier curves among patients in the three groups. Inter-group comparisons were performed using the log-rank test. Cox proportional hazards regression models were used to determine whether overweight and obesity were associated with survival after AVR. The related variables were entered into the Cox analyses of observed survival. Significant (P ≤ 0.1) variables on univariate analysis were re-entered in a multivariable model examining predictors of survival. A propensity score was calculated using a logistic regression analysis that identified variables, which may be associated with BMI. Variables included in the logistic regression analysis were: sex, age, body surface area (BSA), diabetes mellitus, systemic hypertension, chronic lung disease, EOAI and cardiopulmonary bypass (CPB) time. The propensity score was then incorporated into the subsequent proportional hazards models. Results were expressed as the hazard ratio (HR) and 95% of confidence interval (CI). All statistical analyses were carried out using SPSS 17.0 (SPSS, Chicago, IL, USA).
RESULTS
In this study, 62.5% of the patients (n = 185) presented a normal BMI (<24 kg/m 2 ), 30.6% (n = 94) of the patients were overweight and 9.2% (n = 28) were obese. Preoperative and operative data are presented in Table 2 . Compared with the normal-weight group, those patients in the overweight and obese groups had a smaller EOAI, a larger BSA, lower prevalence of atrial fibrillation (AF) and a higher prevalence of diabetes mellitus, systemic hypertension, chronic lung disease and concomitant CABG. In consideration of the degeneration of the bioprostheses, we studied the changes in transvalvular gradient in the biologicaland mechanical-valve groups during the follow-up (Table 3) , and we found the gradient in the bioprostheses group higher than that in the mechanical group at different time points, but the difference was not statistically significant. The changes in BMI and echocardiographic data at different time points of the follow-up are presented in Table 4 . Pulmonary artery systolic pressure reduced significantly over time (P = 0.001); left ventricular endsystolic diameter (P < 0.001) and end-diastolic diameter (P = 0.01) significantly shortened as time progressed after AVR; relative wall thickness decreased from 0.48 ± 0.13 preoperatively to 0.43 ± 0.11 at the third month after AVR, and it showed a further significant change (P < 0.001); BMI increased by 1.7, 5.2, 7.6, 12.9, 15.5, 14.2% at the third month, sixth month, first year, third year, fifth year and eighth year after AVR (P = 0.01). 
Impact of body mass index on mortality
The mean overall follow-up duration was 4.7 ± 2.8 (median: 4.1 years; range: 0.2-10 years). Sixty-eight deaths were observed during the follow-up. The overall survival rates were 81.5 ± 2.6% at 5 years and 54.3 ± 1.4% at 10 years (Fig. 1A) . For obese patients, 5-year survival (65.1 ± 1.8%) and 10-year survival (31.6 ± 1.4%) were significantly lower than those of patients with normal BMI (5-year survival: 85.2 ± 3.6% and 10-year survival: 65 ± 2.2%; P = 0.007; Fig. 1B ). The obese group also had significantly lower survival than the overweight group (5-year survival: 74.8 ± 3.1% and 10-year survival: 52.2 ± 2.0%; P = 0.01). The difference in survival between the normal and overweight groups was also statistically significant (P = 0.03), with the overweight group having a lower survival rate. Among 68 deaths, 40 (58.8%) were classified as being of cardiovascular cause. Freedom from cardiovascularrelated death was significantly lower in patients with obese BMI (5-year survival: 77.2 ± 2.6% and 10-year survival: 52.6 ± 2.1%; P < 0.001; Fig. 1C ) than in those with normal and overweight BMI.
Predictors of mortality
According to the univariate analysis ( (Table 2) , after adjustment of the variables with a P-value ≤0.1 on univariate analysis, the following variables were not independently associated with long-term survival: poor cardiac function, concomitant CABG and the use of a mechanical prosthesis. Overweight failed to be an independent predictor of long-term survival (HR: 0.64; 95% CI: 0.50-0.81; P = 0.45), but obesity remained significantly associated with increased mortality (HR: 1.60; 95% CI: 0.32-1.91; P = 0.008). After adjustment for propensity score, the following variables were independent predictors of long-term survival after AVR: old age, reduced LVEF, diabetes, hypertension, chronic lung disease, EOAI and obesity.
Interaction of body mass index and postoperative NYHA function
In the third and sixth months after operation, the proportion of patients with NYHA Class III/IV in the normal-weight group was higher, but the difference was not statistically significant ( Fig. 2A) . At 1 year, the trend was changed; the proportion in the obesity group grew higher than that of the normal group (P = 0.01). Three years later, amplified discrepancy among the three groups was observed. The proportions of patients with NYHA Class III/IV in the obesity and overweight groups were both higher than in the normal-weight group (P = 0.02), and the gap between obesity and overweight groups was also apparent (P < 0.01). After 3 years, the proportion of patients with NYHA Class III/IV in the obesity and overweight groups rapidly climbed (P < 0.01) year-by-year after AVR. In the normal-weight group, the proportion also increased, but the year-to-year comparisons saw no significant differences.
Impact of body mass index on left ventricular ejection fraction, effective orifice area index and left ventricular mass index
The values of LVEF after operation at different time points in the groups demonstrated no dramatic difference (Fig. 2B) . The values of EOAI in the three groups all decreased in the first year after operation, and a declining trend was observed. EOAI in the third month and the third year were significantly different in the obese and normal-weight groups (Fig. 2C) . The values in the obesity and overweight groups were lower than in the normal group after operation at almost all time points (P < 0.01; Fig. 2C ). Left ventricular mass index (LVMI) values in the three groups dropped sharply in the first year after operation, reaching a minimum value in the third year. LVMI values increased in later years, but the trend was insignificant except in the normal group (P < 0.01; Fig. 2D ). The values in the obesity group were significantly higher than in the overweight and normal-weight groups at different time points (Fig. 2D) ; the difference between the overweight and normal groups was not statistically significant.
DISCUSSION
Here, we reported the long-term follow-up with patients who underwent aortic prosthetic replacement with a smaller prosthesis (size ≤21 mm) in China. A notable finding was that obesity (BMI ≥28 kg/m 2 ) was an independent predictor of late mortality in patients undergoing AVR with a small prosthesis. The obese and overweight groups had poor survival and a higher proportion of NYHA functional Class III/IV, compared with the normal-weight group.
Review of previous studies
There have been some different opinions in the published reports about the impact of BMI on outcomes after AVR, but specialized research on AVR with small prostheses was scarce. Several studies demonstrated that BMI was an independent predictor of mortality and clinical events after AVR. Rahmanian [6] identified obesity as an independent predictor of longer hospitalization and longer mortality in patients who underwent valve surgery. William et al. [7] studied patients having AVR for aortic stenosis with or without concomitant coronary artery bypass grafting, finding better survival in patients with low BMI than in those with higher BMI. However, other studies failed to 
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find a significant effect of BMI on postoperative outcomes. Thourani [8] reported that patients with a BMI of ≤24 were at significantly increased risk of in-hospital and long-term mortalities after cardiac valvular surgery. This high-risk patient population warrants careful risk stratification and options for less invasive valve therapies. Robert et al. [9] found that increasing BMI had no independent association with worsened outcomes in the short-or long-term, and overweight patients actually had a survival benefit after surgery. So the relationship between BMI and long-term survival after AVR was controversial. Long-term survival research on BMI and small aortic roots is rarely reported.
Impact of BMI on long-term mortality and NYHA classification
It is important to note that there may be some differences in AVR between China and Western countries; it is unknown whether this could affect the results of the research. For example, rheumatic disease accounted for the major aetiology in this cohort, although the occurrence of degeneration was on the rise; mechanical valves were mostly used; and patients were younger and had less concomitant CABG.
In this study, we determined that obesity raised long-term mortality, implying that a higher BMI means a higher risk of adverse outcomes for patients with a small aortic prosthesis replacement. These results are consistent with some previous studies [6, 7] . In addition, a higher proportion of patients with poor cardiac function were observed in the obesity group at 1 year after surgery, and that distinction increased over time. These findings suggest that high BMI is a possible indicator of poor long-term quality of life for patients with small aortic roots. Previous studies [10, 11] concluded that the NYHA class of patients could be ameliorated within a short period after operation. Nevertheless, those studies failed to keep up with its change in the subsequent years after AVR.
Long-term outcome of effective orifice area index, left ventricular ejection fraction and left ventricular mass index
Several factors, such as EOAI, LVEF and LVMI, may directly contribute to a higher category of NHYA class in the obesity and overweight groups. We eliminated LVEF from the list due to its insignificant change along with BMI increase. In contrast, EOAI and LVMI were related to BMI in our investigation. As a result, EOAI may be associated with cardiac function and influence postoperative life quality. We also found EOAI too to be an independent predictor of late mortality in this research, which was in accordance with previous research [12] . EOAI ≤0.85 cm 2 /m 2 (considered as PPM) could lead to increased late mortality after AVR. That is why PPM should be avoided in patients with small aortic roots. It is a challenge for surgeons to select the optimal type and size of prosthesis, so that proper EOAI can be maintained in obese patients. Although supra-annular stentless valves have been applied in the recent years to increase EOAI and to prevent PPM, there have been some discrepancies in the results [13, 14] . Annulus-enlarging techniques allow for the implantation ) and red indicates the obesity group (BMI ≥28 kg/m 2 ). *Significant difference from the normal (BMI <24) group; †significant difference from the overweight (BMI 24-27.9) group; ‡ significant difference from the first-year time point in A; § significant difference from the third-month time point in C; ||significant difference from the third-year time point in C. 
Clinical implications
Why does obesity affect the late mortality and NYHA functional class in patients with implantation of small aortic prostheses? We attempted to answer this question in the following aspects: obesity-related diseases, operation techniques and postoperative lifestyle. Overweight or obesity were associated with an increased risk of underlying diseases such as diabetes [16] , hypertension [17] , coronary artery disease [17, 18] and other chronic diseases [19] , which may increase the mortality in the long term. We indicated in this research that diabetes, systemic hypertension and chronic lung disease were independent predictors of late mortality in patients undergoing AVR with small prostheses. So obesity-related diseases should be taken into consideration in advance to evaluate the risk of surgery and to predict long-term outcomes for patients. According to the results of our study, we should reconsider the role of annulus-enlarging techniques even though they are often accompanied by increased morbidity and mortality after AVR. Such techniques may be meaningful to recommend as the best choice for patients with obesity and relatively small aortic annulus requiring AVR, but implantation with small prostheses, especially in younger patients [20] , can effectively increase the EOAI and improve the long-term outcome and quality of life. So in the future, we should work to perfect annulus-enlarging techniques, including reducing the cross-clamp time and the occurrence of complications.
It should be noted that, in the normal-weight group, the EOAI and LVMI also worsened 3 years later in spite of lower later mortality. The main reason may be an increase in BSA. In this study, we were informed that many people gained weight after AVR due to reduced activity and an improper diet. Since height changed little after operation, accumulation of weight may bring about larger BSA. It is important to instruct patients with small prostheses to keep fit and control their weight, which could certainly benefit their health after AVR.
We should note that diabetes mellitus, systemic hypertension and chronic lung disease are associated with late postoperative mortality in this series; this limitation would affect the result to some extent.
CONCLUSIONS
This study analysed the effects of BMI on late mortality in patients undergoing AVR with a small prosthesis. Results suggested that obesity was associated with increased late mortality after AVR in patients with implantation of a small aortic prosthesis (size ≤21 mm). Obesity and overweight may also affect the NYHA function in the long-term. EOAI should be improved where possible as it may reduce late mortality and improve quality of life in such patients.
